Cargando…

Effect of vancomycin loading dose on clinical outcome in critically ill patients with methicillin-resistant Staphylococcus aureus pneumonia

BACKGROUND: Vancomycin is the treatment of choice for serious methicillin-resistant Staphylococcus aureus (MRSA) infections. Current guidelines recommend giving an initial loading dose (LD) of 25–30 mg/kg to rapidly increase the serum concentration. However, high-quality evidence for the clinical be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Jin Gu, Huh, Kyungmin, Sohn, You Min, Park, Hyo Jung, Na, Soo Jin, Jeon, Kyeongman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947502/ https://www.ncbi.nlm.nih.gov/pubmed/33717549 http://dx.doi.org/10.21037/jtd-20-2243

Ejemplares similares

Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria
por: Choe, Junsu, et al.
Publicado: (2019)

Efficacy and safety of vancomycin loading doses in critically ill patients with methicillin-resistant Staphylococcus aureus infection
por: Flannery, Alexander H., et al.
Publicado: (2021)

Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
por: Liang, Jin, et al.
Publicado: (2023)

Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
por: Tian, Ye, et al.
Publicado: (2018)

Predicting methicillin-resistant Staphylococcus aureus in critically ill patients with pneumonia presenting to the hospital
por: Shorr, AF, et al.
Publicado: (2012)

Vancomycin‐Loaded Microneedle Arrays against Methicillin‐Resistant Staphylococcus Aureus Skin Infections
por: Ziesmer, Jill, et al.
Publicado: (2021)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
por: Panesso, Diana, et al.
Publicado: (2015)

Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children With Influenza-related Critical Illness
por: Randolph, Adrienne G, et al.
Publicado: (2019)

Prospective Nasal Screening for Methicillin-Resistant Staphylococcus aureus in Critically Ill Patients With Suspected Pneumonia
por: Raush, Nicholas, et al.
Publicado: (2021)

Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages
por: Howe, Robin A., et al.
Publicado: (2004)

Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
por: Lin, Chien-Yu, et al.
Publicado: (2018)

Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
por: Pletz, Mathias W, et al.
Publicado: (2010)

192 Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
por: Morrill, Haley, et al.
Publicado: (2014)

2003. Vancomycin Discontinuation Is Supported by-negative Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) in Patients with Pneumonia
por: Pleasants, Katherine A, et al.
Publicado: (2019)

Vancomycin Tolerant, Methicillin-Resistant Staphylococcus aureus Reveals the Effects of Vancomycin on Cell Wall Thickening
por: Cázares-Domínguez, Vicenta, et al.
Publicado: (2015)

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aguado, Jose Maria, et al.
Publicado: (2011)

Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci Co-colonization
por: Furuno, Jon P., et al.
Publicado: (2005)

Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus
por: Katayama, Yuki, et al.
Publicado: (2017)

Methicillin-resistant Staphylococcus aureus Necrotizing Pneumonia
por: Monaco, Monica, et al.
Publicado: (2005)

An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany
por: Patel, Dipen A, et al.
Publicado: (2014)

Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
por: Patel, Dipen A, et al.
Publicado: (2014)

Effect of the Methicillin-Resistant Staphylococcus aureus Nasal Polymerase Chain Reaction on Vancomycin Days and Clinical Outcomes in Pneumonia
por: Hendon, Natalie, et al.
Publicado: (2017)

Pilot Study of Aerosolised Plus Intravenous Vancomycin in Mechanically Ventilated Patients with Methicillin-Resistant Staphylococcus Aureus Pneumonia
por: Cho, Jun Yeun, et al.
Publicado: (2020)

Comparison of mortality and clinical failure rates between vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumonia
por: Lee, Jang Ho, et al.
Publicado: (2022)

Efficacy of Combined Vancomycin and Fosfomycin against Methicillin-Resistant Staphylococcus aureus in Biofilms In Vivo
por: Shi, Jian, et al.
Publicado: (2014)

Community-Acquired Necrotizing Pneumonia Caused by ST72-SCCmec Type IV-Methicillin-Resistant Staphylococcus aureus in Korea
por: Hwang, Ji-Won, et al.
Publicado: (2013)

Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
por: Karau, Melissa J, et al.
Publicado: (2013)

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations
por: Mills, Alexandra G., et al.
Publicado: (2023)

Association of time-to-treatment with outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients
por: Ko, Ryoung-Eun, et al.
Publicado: (2019)

Vancomycin Ophthalmic Ointment 1% for methicillin-resistant Staphylococcus aureus or methicillin-resistant Staphylococcus epidermidis infections: a case series
por: Sotozono, Chie, et al.
Publicado: (2013)

Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
por: Mizokami, Fumihiro, et al.
Publicado: (2013)

The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
por: Mizuno, Tomohiro, et al.
Publicado: (2013)

Vancomycin MIC Distribution among Methicillin-Resistant Staphylococcus Aureus. Is Reduced Vancomycin Susceptibility Related To MIC Creep?
por: Othman, Hala B., et al.
Publicado: (2018)

Methicillin-Resistant Staphylococcus aureus-Associated Diarrhea in a Critically Ill Burn Patient
por: Malkoc, Aldin, et al.
Publicado: (2021)

Pneumonia and New Methicillin-resistant Staphylococcus aureus Clone
por: Garnier, Fabien, et al.
Publicado: (2006)

Metabolic Adaptation in Methicillin-Resistant Staphylococcus aureus Pneumonia
por: Gabryszewski, Stanislaw J., et al.
Publicado: (2019)

Necrotizing pneumonia caused by methicillin‐resistant Staphylococcus aureus
por: Hiramatsu, Toshiki, et al.
Publicado: (2022)

Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast China
por: Hu, Jian, et al.
Publicado: (2013)

Vancomycin (VAN) Combinations with Β-Lactams (BLs) against Methicillin-Resistant Staphylococcus aureus (MRSA), Heterogeneous Intermediate-Level Resistance to Vancomycin (hVISA) and Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Tran, Kieu-Nhi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d71cf11rfac1q3n9m6cmmjo1ls